Text Size

Transoesophageal Echocardiography in Liver Transplantation

The recruitment status of this study is unknown because the information has not been verified recently.
Verified October 2009 by University of Zurich.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
University of Zurich
ClinicalTrials.gov Identifier:
NCT00547924
First received: October 22, 2007
Last updated: October 22, 2009
Last verified: October 2009
History of Changes
  Purpose

Severe hypotension during reperfusion in liver transplantation is a frequent adverse event. Rare data exist so far about pathophysiology of this phenomenon. The exact role of left ventricular function, which might be impaired causing hypotension, has not been elucidated during the period of reperfusion.

Goal of this study is to:

  • perform transesophageal echocardiography in order to assess systolic and diastolic left ventricular function during reperfusion
  • determine inflammatory mediators in the plasma which could cause left ventricular dysfunction

Condition Intervention
End Stage Liver Disease
 Behavioral: Transoesophageal echocardiography

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Transoesophageal Echocardiography in Liver Transplantation: Left Ventricular Function During Reperfusion

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by University of Zurich:

Estimated Enrollment: 17
Study Start Date: April 2006
Estimated Study Completion Date: July 2010
Estimated Primary Completion Date: July 2010 (Final data collection date for primary outcome measure)
Intervention Details:
    Behavioral: Transoesophageal echocardiography
    Transoesophageal echocardiography in liver transplantation: left ventricular function during reperfusion
  Eligibility

Ages Eligible for Study:   18 Years to 75 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Patients on waiting list for liver transplantation

Criteria

Inclusion criteria:

  • Patients on waiting list for liver transplantation.
  • Age: 18-75 years.

Exclusion criteria:

  • Strictures, tumours and diverticula of the oesophagus.
  • History of oesophageal varices with recent bleeding.
  • Oesophageal varices and prothrombin time less than 20% or platetlets les than 30000/ml.
  • Instable cervical spine.
  • Involvement in other studies.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00547924

Contacts
Contact: Marco Zalunardo, MD +41 (0)44 255 11 11 marco.zalunardo@usz.ch

Locations
Switzerland
University Hospital Zurich, Institute for Anesthesiology Recruiting
Zurich, Switzerland
Contact: Marco Zalunardo, MD         marco.zalunardo@usz.ch    
Sponsors and Collaborators
University of Zurich
Investigators
Principal Investigator: Marco Zalunardo, MD UniversitaetsSpital Zuerich
  More Information

No publications provided

Responsible Party: Marco P. Zalunardo, Institute of Anesthesiology, University Hospital Zurich
ClinicalTrials.gov Identifier: NCT00547924     History of Changes
Other Study ID Numbers: StV 11-2006
Study First Received: October 22, 2007
Last Updated: October 22, 2009
Health Authority: Switzerland: Swissmedic

Additional relevant MeSH terms:
Liver Diseases
End Stage Liver Disease
Digestive System Diseases
Liver Failure
Hepatic Insufficiency

ClinicalTrials.gov processed this record on May 16, 2013